Re-expression of miRNAs of the miR-200 family reduced expression of its target genes, including ZEB1, ZEB2, FN1 and class III β-tubulin (TUBB3), and inhibited ovarian cancer cell migration and invasion (Cochrane et al, 2009; Hu et al, 2009). The gene discussed is ZEB2; the disease is ovarian carcinoma.